Emerging & Novel Therapies

The microvascular complications of insufficiently controlled diabetes (neuropathy, retinopathy and nephropathy) and the marked increased risk of macrovascular events (e.g., stroke and myocardial infarction) have a dire impact on society in both human and economic terms. In Type 1 diabetes total β-cell loss occurs. In Type 2 diabetes, partial β-cell loss occurs before diagnosis, and the progressive β-cell loss during the life of the patient increases the severity of the disease. In patients with diabetes, increased insulin resistance in the muscle and liver are key pathophysiologic defects. In addition, defects in metabolic processes in the fat, GI tract, brain, pancreatic α-cells and kidney are detrimental to the overall health of the patient. This review addresses novel therapies for these deficiencies in clinical and preclinical evaluation, emphasizing their potential to address glucose homeostasis, β-cell mass and function, and the comorbidities of cardiovascular disease and obesity.

    Related Conference of Emerging & Novel Therapies

    July 23-24, 2018

    Global Meeting on Diabetes and Endocrinology

    Kuala Lumpur, Malaysia
    August 20-21, 2018

    28th World Congress on Diabetes, Obesity & Heart

    Tokyo, Japan
    September 03-04, 2018

    2nd International Conference on Thyroid and Pregnancy

    Auckland, New Zealand
    September 3-4, 2018

    11th World Congress on Endocrinology and Metabolic Disorders

    Auckland, New Zealand
    November 21-22, 2018

    14th World Congress on Endocrinology & Diabetes

    | Paris, France
    September 28-29, 2018

    2nd International Conference on Diabetes and Diabetic Nursing Care

    Montreal, Quebec, Canada
    November 26-27, 2018

    26th International Diabetes and Healthcare Conference

    Helsinki, Finland
    November 26-27, 2018

    13th European Diabetes and Endocrinology Congress

    Dublin, Ireland
    April 26-27, 2019

    12th International Conference on Diabetes & Metabolism

    Houston | Texas | USA

    28th European Diabetes Congress

    June 10-11, 2019 | Edinburgh, Scotland
    Dec 14-15, 2019

    Euro Diabetes Congress & Expo

    | Prague, Czech Republic

    Emerging & Novel Therapies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in